Tandem —

Visit website
Request Update

About Tandem

At Tandem Diabetes Care, we envision a future where diabetes management is seamlessly integrated into daily life through innovative technology that redefines the treatment experience. Our mission is to ease the burden of insulin therapy and improve outcomes by delivering advanced, user-friendly insulin delivery systems powered by breakthrough automated technologies.

We are harnessing predictive algorithms, smart design, and clinical rigor to transform how people living with diabetes interact with their care. By pioneering automated insulin delivery systems such as Control-IQ+, we are creating devices that adapt intuitively to individual needs, empowering patients and healthcare providers alike.

Tandem Diabetes Care is dedicated to advancing the future of diabetes treatment through continual innovation and strategic partnerships, building a world where technology enables healthier lives and greater freedom for those managing diabetes every day.

Our Review

We've been tracking Tandem Diabetes Care since they shook up the insulin pump market, and honestly, they've impressed us more than we expected. This isn't your typical medical device company that treats patients like an afterthought—they actually seem to get what it's like to live with diabetes.

What caught our attention first was their origin story. Back in 2006, a group of engineers looked at the clunky insulin pumps on the market and basically said, "We can do better." They spent serious time talking to over 4,000 pump users and healthcare providers before building anything. That's the kind of research-first approach we love to see.

The Tech That Actually Makes Sense

Their t:slim X2 pump is where things get interesting. Instead of the usual medical device interface that feels like it's from 2005, you get a color touchscreen that actually responds like your smartphone. The Control-IQ+ technology is doing some clever predictive work—it's not just reacting to blood sugar changes, it's trying to prevent them.

We're particularly excited about their Tandem Mobi system. It's compact enough that you can wear it almost anywhere, and the smartphone control means you're not fumbling with a separate device all the time. For people who want diabetes management to fit their lifestyle instead of dominating it, this feels like a game-changer.

What Sets Them Apart

Here's what we find most impressive: Tandem is the only company with clinical trial data showing their automated insulin delivery system works for type 2 diabetes patients, not just type 1. That's a much bigger market, and frankly, a more complex challenge to solve.

Their partnership strategy is smart too. Instead of trying to build everything in-house, they're working with established players like Dexcom and Abbott for continuous glucose monitoring. That means better integration and fewer headaches for users who want best-in-class components working together seamlessly.

Who Should Pay Attention

If you're someone who's frustrated with outdated pump interfaces or you're tired of diabetes management feeling like a full-time job, Tandem deserves a serious look. Their user-centric design philosophy isn't just marketing speak—it shows up in the actual products.

We're also keeping an eye on their pipeline. The Sigi rechargeable patch pump and their work toward fully closed-loop systems suggest they're not resting on their current success. For a publicly traded company (TNDM), they're taking the right kinds of calculated risks to stay ahead of the curve.

Features

Platform Type
Website
Pricing
Contact for pricing
Features

t:slim X2 Insulin Pump with Control-IQ+ hybrid closed-loop technology

Tandem Mobi System, a compact smartphone-controllable insulin pump

Control-IQ+ automated insulin delivery system with predictive algorithms and AutoBolus

Development of rechargeable patch pump (Sigi) and extended wear infusion technology

Integration with continuous glucose monitoring (CGM) systems from Dexcom and Abbott

Jobs

There is no job at the moment.

FAQs

When was Ploy founded?

Ploy was founded in 2024.

Last Update
August 7, 2026
Categories
Healthcare
Automation
Companies size
1001-5000
Country
United States
Bio

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem is the #1 recommended insulin pump brand by people living with diabetes, four years and counting. (dQ&A US Diabetes Connections Patient Panel Report; Net Promoter Score; Q1 2019-Q3 2023: P.49, Q3 2023 (Jan. 2019-Sept. 2023). Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com. SAFETY INFORMATION Please note that this account is not intended to be used for product support or medical advice. If you are having a medical emergency, please dial 911. If you are having an issue with one of our products and need immediate assistance, please call our 24-hour customer support team at 877-801-6901 and press 1 twice. RX ONLY. Indicated for patients with type 1 diabetes, 6 years and older. WARNING: Control-IQ technology should not be used by people under age 6, or who use less than 10 units of insulin/day, or who weigh less than 55 lbs. Safety info: tandemdiabetes.com/safetyinfo.

Medical Equipment Manufacturing